Fitness Costs of Fluoroquinolone Resistance in Streptococcus pneumoniae
- 1 February 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (2) , 412-416
- https://doi.org/10.1128/aac.01161-06
Abstract
The fitness cost of the genes responsible for resistance to fluoroquinolones in clinical isolates of Streptococcus pneumoniae were estimated in vitro in a common genetic background. Naturally occurring parC , parE , and gyrA loci containing mutations in the quinolone-resistance-determining regions were introduced by transformation into S. pneumoniae strain R6 individually and in combinations. The fitness of these transformants was estimated by pairwise competition experiments with a common R6 strain. On average, single par and gyr mutants responsible for low-level MIC resistance (first-step resistance) impose a fitness burden of approximately 8%. Some of these mutants engender no measurable cost, while one, a parE mutant, reduces the fitness of these bacteria by more than 40%. Most interestingly, the addition of the second par or gyr mutations required for clinically significant, high-MIC fluoroquinolone resistance does not increase the fitness burden imposed by these single genes and can even reduce it. We discuss the implications of these results for the epidemiology of fluoroquinolone resistance and the evolution of acquired resistance in treated patients.Keywords
This publication has 57 references indexed in Scilit:
- The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosisScience, 2006
- Incremental Increase in Fitness Cost with Increased β‐Lactam Resistance in Pneumococci Evaluated by Competition in an Infant Rat Nasal Colonization ModelThe Journal of Infectious Diseases, 2006
- Prevalence of First-Step Mutants among Levofloxacin-Susceptible Invasive Isolates of Streptococcus pneumoniae in the United StatesAntimicrobial Agents and Chemotherapy, 2006
- Drug-resistant pneumococcal pneumonia: clinical relevance and approach to managementEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Relative Fitness of Fluoroquinolone-resistantStreptococcus pneumoniaeEmerging Infectious Diseases, 2005
- Interspecies Recombination in Type II Topoisomerase Genes Is Not a Major Cause of Fluoroquinolone Resistance in Invasive Streptococcus pneumoniae Isolates in the United StatesAntimicrobial Agents and Chemotherapy, 2005
- Fluoroquinolone-Resistant Pneumococci: Maybe Resistance Isn't Futile?Clinical Infectious Diseases, 2005
- Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Predicting Bacteremia at the BedsideClinical Infectious Diseases, 2004
- Long-Term Experimental Evolution in Escherichia coli. I. Adaptation and Divergence During 2,000 GenerationsThe American Naturalist, 1991